{
    "SPADE_UN_29699": {
        "Sequence Information": {
            "Peptide Name": "Trichogin GA IV [G2K]",
            "Sequence": "XKLXGGLXGI",
            "Sequence Length": 10,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity.",
                    "Pubmed ID": "25306964",
                    "Reference": "Biochim Biophys Acta. 2015;1848:134-144",
                    "Author": "Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25306964"
                }
            ],
            "SPADE ID": "SPADE_UN_29699",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_01118",
                    "Similarity": 1.0,
                    "Sequence": "GLLDFAKHVIGIASKLG"
                },
                {
                    "SPADE_ID": "SPADE_N_01207",
                    "Similarity": 1.0,
                    "Sequence": "FLSLLPSIVSGAVSLAKKLG"
                },
                {
                    "SPADE_ID": "SPADE_N_06458",
                    "Similarity": 1.0,
                    "Sequence": "RWQWRMKKLG"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:0% Hemolysis=4 µM,Human erythrocytes:8% Hemolysis=8 µM,Human erythrocytes:35% Hemolysis=16 µM",
            "Target Organism": "Staphylococcus aureus(MIC=3±1.4µM),Staphylococcus epidermidis(MIC=4.3±2µM),Pseudomonas aeruginosa(MIC=58±16µM),Escherichia coli(MIC=24±17.1µM),Human cervical carcinoma HeLa(EC50=6µM),Human epidermoid carcinoma A431(EC50=6µM),Human promyelocytic leukemia HL-60(EC50=11µM),Human lung carcinoma A549(EC50=7µM)"
        }
    }
}